{"id":"W2807161544","doi":"10.1093/jnci/djy094","title":"Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients","year":2018,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute; Genentech; Novartis Pharma; Astellas Pharma; European Society for Medical Oncology; Alliance for Clinical Trials in Oncology Foundation; Teva Pharmaceutical Industries; Novartis; GlaxoSmithKline; Eli Lilly and Company","keywords":"Lapatinib; Trastuzumab; Medicine; Oncology; Internal medicine; Hazard ratio; Breast cancer; Interquartile range; Cohort; Gynecology; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005350953,0.00009993812,0.0003058824,0.0001950192,0.0001757159,0.0002594129,0.0001160617,0.0002331269,0.001102797],"category_scores_gemma":[0.00139157,0.00009229765,0.000345671,0.0003669272,0.0001185373,0.0001491832,0.000141398,0.000281331,0.00007813264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002362108,"about_ca_system_score_gemma":0.0002768417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001224262,"about_ca_topic_score_gemma":0.002455035,"domain_scores_codex":[0.9998657,0.00004538768,0.00001406242,0.00002524738,0.0000234281,0.00002615089],"domain_scores_gemma":[0.999324,0.0002021564,0.0002841704,0.000026172,0.00002418264,0.0001393792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009387335,0.0001848258,0.9787637,0.00005759037,0.0001921162,0.0001132167,0.00004320684,0.0001867403,0.0005244903,0.0000235393,0.0001830804,0.01034015],"study_design_scores_gemma":[0.0003165897,0.001713883,0.99661,0.00001652552,0.0001401867,0.0002531776,0.00004878052,0.0002636348,0.0001105274,0.00005537392,0.0004667133,0.000004564202],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981452,0.001383884,0.00002358271,0.00003419658,0.000004948276,0.000008198658,0.0002066962,0.000001377389,0.0001919078],"genre_scores_gemma":[0.9993529,0.0002775636,0.0000367588,0.00003717586,0.000008622368,0.00001028119,0.0001927315,4.713118e-7,0.00008362153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001224262,"threshold_uncertainty_score":0.003689229,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05072946608820937,"score_gpt":0.37832727657369,"score_spread":0.3275978104854806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}